Statistics for Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma
Total visits
| views | |
|---|---|
| Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma | 0 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:fa0cb5c3-3bfc-40e6-ba9b-94eb6c6f4267 | 23 |
| java.util.UUID:a2064e3b-b016-4926-9328-a3eb235467ff | 20 |
| java.util.UUID:1345d5c7-0fb9-4c41-afb9-748236501bb5 | 6 |
| Marino2024Pharmacologic-CCBYNC.pdf | 1 |